Hypertension Cost Is Staggering: Solutions -- Any Drug, IT, and a Vaccine?

109 97
´╗┐Hypertension Cost Is Staggering: Solutions -- Any Drug, IT, and a Vaccine?


Blood pressure elevated to the point that it is classified as hypertension is a largely asymptomatic condition that is widely underrecognized and uncontrolled, worldwide. This is not a benign condition with which we simply must live; indeed, when direct and indirect costs are included, the total cost to the world's healthcare systems amounts to $10 trillion annually. A meta-analysis by the original authors of the "polypill" concept, however, has found that appropriate application of any blood pressure-lowering regimen in patients at high cardiovascular disease (CVD) risk will be effective in preventing CVD events, and a Canadian study found that monitoring antihypertensive therapy with an information technology (IT) program will increase blood pressure control. Finally, cytomegalovirus (CMV) infection, which infects 60% to 99% of adults worldwide, is associated with increased blood pressure, and the recent disappointment with a promising antihypertensive vaccine now appears to have been due to a mistaken belief that the dosage level should be lower.

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.